Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system
Conditions
Interventions
Intervention1: Karisalai Karpa chooranam
Linga chenduram ( Special)
Vetrilai thylam: 1.KARISALAI KARPA CHOORANAM - 500mg to 1gm administered orally Twice a day with honey for 20 days,
2.LINGA CHENDUR
Sponsors
Dr R Kamalinie
Eligibility
Inclusion criteria
Inclusion criteria: Patient must have a confirmed diagnosis of Duschene Muscular dystrophy through Clinical examination,genetic testing and muscle biopsy
Exclusion criteria
Exclusion criteria: Presence of other neuromuscular disorder such as Motor neuron diseases,Spinal muscular atrophy and other types of muscular dystrophy except DMD
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The expected outcomes for the Management of Melmoochu vatham (Muscular dystrophy) with the trial drug KARISALAI KARPA CHOORANAM, LINGA CHENDURAM (Special) and VETRILAI THYLAM will include improvements in muscle strength, mobility and overall quality of life for patients. Timepoint: 2 weeks and 4 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| The drug may potentially slow down disease progression, reduce muscle degeneration & alleviate symptoms such as muscle weakness & fatigue.Timepoint: 2 weeks & 4 weeks | — |
Countries
India
Contacts
Public ContactDr. K.SHYAMALA
Government Siddha Medical College and Hospital,Palayamkottai
Outcome results
None listed